Predictors of serum testosterone and DHEAS in African-American men.
There are few reported data on biochemical and functional correlates of androgen levels in African-American men. This study aimed at reporting physical and biochemical correlates of serum total testosterone (total T), bioavailable testosterone (BT) and dehydroepiandrosterone-sulphate (DHEAS) levels in community-dwelling, African-American men aged 50-65 years. Home-based physical examinations and health status questionnaires were administered to randomly sampled men. Body composition (dual-energy X-ray absorptiometry), lower limb and hand-grip muscle strength, and neuropsychological functions were assessed. Levels of serum total T, BT, DHEAS, oestradiol (E2), adiponectin, leptin, triglycerides and glucose were measured. Multiple linear regression models were constructed to identify factors independently associated with androgen levels. DHEAS levels declined from age 50 to 65 years (p < 0.0001), but total T and BT levels remained constant. Independent of other associated factors, higher total T levels were associated with lower serum triglyceride levels (beta = -0.142, p = 0.049); higher BT was associated with better performance on the trail-making tests (TMT-B:TMT-A ratio: beta = -0.118, p = 0.024) and higher DHEAS levels were associated with lower adiponectin (beta = -0.293, p = 0.047) and higher mini-mental state examination (MMSE) score (beta = 0.098, p = 0.008). Multiple regression models predicted 21, 18 and 29% of variance in total T, BT and DHEAS, respectively. Higher total T levels were associated with serum metabolic markers, particularly lower triglycerides, whereas higher BT was associated with better cognitive and muscle function and DHEAS with lower adiponectin and higher MMSE scores.
Haren
Matthew T
MT
Division of Geriatric Medicine, Saint Louis University School of Medicine, St Louis, MO, USA.
Banks
William A
WA
Perry Iii
H M
HM
Patrick
Ping
P
Malmstrom
Theodore K
TK
Miller
Douglas K
DK
Morley
John E
JE
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D001741:Black or African American; D000368:Aged; D000375:Aging / Q000097:blood; D001682:Biological Availability; D001769:Blood / Q000378:metabolism; D001823:Body Composition; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007006:Hypogonadism / Q000097:blood; D007182:Income; D008297:Male; D008875:Middle Aged; D008962:Models, Theoretical; D053580:Muscle Strength; D018482:Muscle, Skeletal / Q000502:physiology; D009483:Neuropsychological Tests; D011237:Predictive Value of Tests; D012907:Smoking; D013383:Suburban Population; D013739:Testosterone / Q000097:blood*; D014505:Urban Population
D000319:Adrenergic beta-Antagonists; D007004:Hypoglycemic Agents; D013739:Testosterone; D019314:Dehydroepiandrosterone Sulfate